ORTHOBOND CORPORATION
Princeton, NJ · CIK 0001329147 · Medtech · Private
Antimicrobial nanosurfaces applied to device and material surfaces
orthobond.com →- Grants
- $293K
- 2 awards
- Sector median: 1
- Raised
- $12M
- 3 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 19
- 5 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,147,092 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Antimicrobial Pedicle Screw System: Studies Designed to Mitigate the Risk of Bacterial Resistance | $146,428 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Antimicrobial Pedicle Screw System:Studies Designed to Mitigate the Risk of Bacterial Resistance | $146,428 | |
| Private capital raised | Form D · SEC | $1,075,000 | |
| Private capital raised | Form D · SEC | $8,346,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 863 | Gelesis | — | $38M |
| 864 | FUSmobile | — | — |
| 865 | Afraxis, Inc. | — | $2.9M |
| 866 | ORTHOBOND CORPORATION | — | $12M |
| 867 | WINTER INNOVATIONS INC. | — | $2.1M |
| 868 | Boston Heart Diagnostics Corp | — | $10M |
| 869 | MAD Apparel, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Khalil BarrageDirector
- Marc BurelExecutive Officer
- Frank CammisaDirector
- Lisa D'OrsoDirector
- Lisa D'UrsoDirector
- Peter GoodwinDirector
- David HelfetDirector
- Gregory LutzDirector · Executive Officer · Promoter
- Eric MilledgeDirector
- David NicholsDirector · Executive Officer
- Peter ScaturroDirector
- Jeffrey SchwartzDirector · Promoter
- Paul VolovichExecutive Officer
- Donald YoungDirector · Executive Officer
Patents
- Antimicrobial And Antiviral Treatments Of Materialsapplication
- Functional Surfacesapplication
- Methods of Photografting to Surface Metal Oxidesapplication
- Functional Surfacesapplication
- Functional Surfacesgranted
- Methods, Compositions And Techniques For Polydimethylsiloxane Surface Modificationsgranted
- Surface Modified Biological Materialsgranted
- Surface Adhesive for Devicesgranted
- Surfaces with Oligomeric or Polymeric Antimicrobialsgranted
- Methods For Detecting And Analyzing Surface Filmsapplication
- Quaternary Phosphonium Coated Surfaces And Methods Of Making The Sameapplication
- Method For The Synthesis Of Acrylate Derivativesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.